Zobrazeno 1 - 10
of 29
pro vyhledávání: '"M G, Aman"'
Autor:
B. J. Freeman, L. E. Arnold, M. G. Aman, Christopher J. McDougle, P. Cronin, B. Vitiello, P. Walson, N. A. Votolato, Fred R. Volkmar, L. Ritz, L. Scahill, M. A. Riddle, David J. Posey, J. J. McGough, James T. McCracken, A. Martin, E. Tierney, Naomi B. Swiezy
Publikováno v:
Child and Adolescent Psychiatric Clinics of North America. 9:201-224
This article reviews the background and rationale for the choice of the atypical antipsychotic agent risperidone as the first drug to be studied by the RUPP Autism Network. Risperidone has potent effects on serotonin and dopamine neuronal systems, wh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b2061520af6aa59751f22df07bae724a
https://doi.org/10.1016/s1056-4993(18)30142-1
https://doi.org/10.1016/s1056-4993(18)30142-1
Autor:
S N, Grondhuis, M G, Aman
Publikováno v:
Journal of intellectual disability research : JIDR. 58(9)
Elevated weight status has become a leading problem for adults and children around the world, regardless of the presence or lack of disability. Youth with intellectual and developmental disabilities are more vulnerable than the typical population to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e7feee869c72fbd631e51d7839deef36
https://pubmed.ncbi.nlm.nih.gov/24020517
https://pubmed.ncbi.nlm.nih.gov/24020517
Autor:
M G, Aman, K S, Langworthy
Publikováno v:
Journal of autism and developmental disorders. 30(5)
We reviewed pharmacological treatments used in children with autism and PDD-NOS who present with hyperactive symptoms. Some 41 studies were identified from the following drug categories: antipsychotics (n = 13), serotonin reuptake inhibitors (n = 3),
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::25a4853606bd860bcfb155a04ad2b57e
https://pubmed.ncbi.nlm.nih.gov/11098883
https://pubmed.ncbi.nlm.nih.gov/11098883
Autor:
M G, Aman, S A, Armstrong
Publikováno v:
Journal of autism and developmental disorders. 30(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fb32343b17dd7b1bf0f29dc017c1686c
https://pubmed.ncbi.nlm.nih.gov/10819123
https://pubmed.ncbi.nlm.nih.gov/10819123
Autor:
C J, McDougle, L, Scahill, J T, McCracken, M G, Aman, E, Tierney, L E, Arnold, B J, Freeman, A, Martin, J J, McGough, P, Cronin, D J, Posey, M A, Riddle, L, Ritz, N B, Swiezy, B, Vitiello, F R, Volkmar, N A, Votolato, P, Walson
Publikováno v:
Child and adolescent psychiatric clinics of North America. 9(1)
This article has reviewed the background and rationale for the choice of risperidone as the first drug to be studied by the RUPP Autism Network. Risperidone has potent effects on 5-HT and DA neuronal systems, both of which have been implicated in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e2097e30e4647b9bd4fa851fd3487c95
https://pubmed.ncbi.nlm.nih.gov/10674197
https://pubmed.ncbi.nlm.nih.gov/10674197
Autor:
L E, Arnold, M G, Aman, A, Martin, A, Collier-Crespin, B, Vitiello, E, Tierney, R, Asarnow, F, Bell-Bradshaw, B J, Freeman, P, Gates-Ulanet, A, Klin, J T, McCracken, C J, McDougle, J J, McGough, D J, Posey, L, Scahill, N B, Swiezy, L, Ritz, F, Volkmar
Assessment of autistic disorder (autism) symptoms, primary and secondary, poses more challenging problems than ordinarily found in multisite randomized clinical trial (RCT) assessments. For example, subjects may be uncommunicative and extremely heter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::31b5af4056e27afecc0611f47693e4ed
http://hdl.handle.net/2318/1646471
http://hdl.handle.net/2318/1646471
Publikováno v:
Research in developmental disabilities. 19(1)
Forty elderly persons with mental retardation were assessed by their care providers on a modified version of the Short Informant Questionnaire on Cognitive Decline in The Elderly (IQCODE) an instrument designed to quantify cognitive decline in elderl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::936c825b7ec266f34b9c25972d15523a
https://pubmed.ncbi.nlm.nih.gov/9472135
https://pubmed.ncbi.nlm.nih.gov/9472135
Publikováno v:
Journal of autism and developmental disorders. 27(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bbcb9a5eadae768b9dd536f3c2f5d936
https://pubmed.ncbi.nlm.nih.gov/9229265
https://pubmed.ncbi.nlm.nih.gov/9229265
Publikováno v:
American journal of mental retardation : AJMR. 101(5)
A double-blind, placebo-controlled, crossover study of methylphenidate (0.4 mg/kgday) and different doses of fenfluramine (1.0, 1.5, or 2.0 mg/g/day) in children with mental retardation or borderline IQ and ADHD was conducted. Parents, teachers, exam
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0655f791b56d2b124b62d9142fffddb2
https://pubmed.ncbi.nlm.nih.gov/9083608
https://pubmed.ncbi.nlm.nih.gov/9083608
Publikováno v:
Research in developmental disabilities. 17(1)
The Nisonger CBRF is a new informant behavior rating scale that was adapted for assessing children and adolescents with mental retardation. A total of 369 children referred to interdisciplinary diagnostic clinics for children with developmental disab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e6a3cbbd56a10a5696fff0569e5e7c75
https://pubmed.ncbi.nlm.nih.gov/8750076
https://pubmed.ncbi.nlm.nih.gov/8750076